Immunic (IMUX) Assets Average (2014 - 2026)

Immunic has reported Assets Average for 13 years, with the latest figure at $106.9 million in Q1 2026.

• Quarterly Assets Average rose 248.3% year-over-year to $106.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $106.9 million (up 248.3% YoY) and the FY2025 annual result came in at $32.5 million, down 31.78% from the prior year.
• Assets Average advanced to $106.9 million in Q1 2026 per IMUX's latest filing, from $32.4 million in the prior quarter.
• Over five years, Assets Average peaked at $144.5 million in Q1 2022 and troughed at $30.7 million in Q1 2025.
• A 5-year average of $86.1 million and a median of $79.2 million in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2025 and 2026: Assets Average plunged 61.26% in 2025, then jumped 248.3% in 2026.
• Over 5 years, Assets Average stood at $124.4 million in 2022, then tumbled by 51.26% to $60.6 million in 2023, then declined by 12.9% to $52.8 million in 2024, then sank by 38.7% to $32.4 million in 2025, then soared by 230.15% to $106.9 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $106.9 million, $32.4 million, and $51.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.